180 related articles for article (PubMed ID: 30872112)
21. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
[TBL] [Abstract][Full Text] [Related]
22. Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk.
Nan H; Qureshi AA; Hunter DJ; Han J
Br J Dermatol; 2008 Aug; 159(2):314-21. PubMed ID: 18510673
[TBL] [Abstract][Full Text] [Related]
23. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
[TBL] [Abstract][Full Text] [Related]
24. MC1R variants increase risk of melanomas harboring BRAF mutations.
Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
[TBL] [Abstract][Full Text] [Related]
25. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
26. MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project.
Tagliabue E; Fargnoli MC; Gandini S; Maisonneuve P; Liu F; Kayser M; Nijsten T; Han J; Kumar R; Gruis NA; Ferrucci L; Branicki W; Dwyer T; Blizzard L; Helsing P; Autier P; García-Borrón JC; Kanetsky PA; Landi MT; Little J; Newton-Bishop J; Sera F; Raimondi S;
Br J Cancer; 2015 Jul; 113(2):354-63. PubMed ID: 26103569
[TBL] [Abstract][Full Text] [Related]
27. Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanoma.
Calbet-Llopart N; Combalia M; Kiroglu A; Potrony M; Tell-Martí G; Combalia A; Brugues A; Podlipnik S; Carrera C; Puig S; Malvehy J; Puig-Butillé JA
Br J Dermatol; 2022 Nov; 187(5):753-764. PubMed ID: 35701387
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of patients with cutaneous melanoma according to variants in the melanocortin 1 receptor gene.
Peña-Vilabelda MM; García-Casado Z; Requena C; Traves V; López-Guerrero JA; Guillén C; Kumar R; Nagore E
Actas Dermosifiliogr; 2014 Mar; 105(2):159-71. PubMed ID: 24238329
[TBL] [Abstract][Full Text] [Related]
29. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF.
Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S
Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
[TBL] [Abstract][Full Text] [Related]
31. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
[TBL] [Abstract][Full Text] [Related]
32. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
33. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
[TBL] [Abstract][Full Text] [Related]
34. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
[TBL] [Abstract][Full Text] [Related]
35. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
[TBL] [Abstract][Full Text] [Related]
36. Germline MC1R variants and frequency of somatic BRAF, NRAS, and TERT mutations in melanoma: Literature review and meta-analysis.
Zanna I; Caini S; Raimondi S; Saieva C; Masala G; Massi D; Cocorocchio E; Queirolo P; Stanganelli I; Gandini S
Mol Carcinog; 2021 Mar; 60(3):167-171. PubMed ID: 33444485
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
38. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
[TBL] [Abstract][Full Text] [Related]
39. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
[TBL] [Abstract][Full Text] [Related]
40. Human Determinants and the Role of Melanocortin-1 Receptor Variants in Melanoma Risk Independent of UV Radiation Exposure.
Wendt J; Rauscher S; Burgstaller-Muehlbacher S; Fae I; Fischer G; Pehamberger H; Okamoto I
JAMA Dermatol; 2016 Jul; 152(7):776-82. PubMed ID: 27050141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
